Shalini Sharp

2012 - Ultragenyx Pharmaceutical

In 2012, Shalini Sharp earned a total compensation of $303.5K as Chief Financial Officer and Senior Vice President at Ultragenyx Pharmaceutical.

Compensation breakdown

Non-Equity Incentive Plan$51,560
Option Awards$90,042
Salary$148,669
Other$13,228
Total$303,499

Sharp received $148.7K in salary, accounting for 49% of the total pay in 2012.

Sharp also received $51.6K in non-equity incentive plan, $90K in option awards and $13.2K in other compensation.

Rankings

In 2012, Shalini Sharp's compensation ranked 10,104th out of 11,487 executives tracked by ExecPay. In other words, Sharp earned more than 12.0% of executives.

ClassificationRankingPercentile
All
10,104
out of 11,487
12th
Division
Manufacturing
3,748
out of 4,253
12th
Major group
Chemicals And Allied Products
1,048
out of 1,203
13th
Industry group
Drugs
801
out of 925
13th
Industry
Pharmaceutical Preparations
607
out of 700
13th
Source: SEC filing on May 23, 2014.

Sharp's colleagues

We found two more compensation records of executives who worked with Shalini Sharp at Ultragenyx Pharmaceutical in 2012.

2012

Emil Kakkis

Ultragenyx Pharmaceutical

Chief Executive Officer

2012

Thomas Kassberg

Ultragenyx Pharmaceutical

Chief Business Officer and Senior Vice President

News

You may also like